These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10153971)

  • 21. Biotech's wonder ride.
    Rynecki D
    Fortune; 2000 Mar; 141(5):435-6. PubMed ID: 10788046
    [No Abstract]   [Full Text] [Related]  

  • 22. Any diamonds in the diagnostic coal?
    Jacobs T
    Nat Biotechnol; 2006 Aug; 24(8):930. PubMed ID: 16900133
    [No Abstract]   [Full Text] [Related]  

  • 23. Bugs or drugs, tortoises or hares?
    Jacobs T
    Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
    [No Abstract]   [Full Text] [Related]  

  • 24. The stampede to convertibles.
    Jacobs T
    Nat Biotechnol; 2003 Aug; 21(8):855. PubMed ID: 12894195
    [No Abstract]   [Full Text] [Related]  

  • 25. Investors remain wary after first quarter downturn.
    Fletcher L
    Nat Biotechnol; 2002 May; 20(5):413-4. PubMed ID: 11981536
    [No Abstract]   [Full Text] [Related]  

  • 26. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 27. There's still gold in them thar pills.
    O'Reilly B
    Fortune; 2001 Jul; 144(2):58-62, 66-8, 70. PubMed ID: 11471355
    [No Abstract]   [Full Text] [Related]  

  • 28. Biotechs hold their own in shifting industry.
    Mitchell P
    Nat Biotechnol; 2002 Nov; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract]   [Full Text] [Related]  

  • 29. In search of the élite.
    Gewin V
    Nature; 2003 Dec; 426(6967):713-7. PubMed ID: 14668879
    [No Abstract]   [Full Text] [Related]  

  • 30. Trends in biopharmaceutical IPOS: 1996-2005.
    Williams DR; Young CC
    J Health Care Finance; 2006; 33(2):39-54. PubMed ID: 19175239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Take a pill and call me tonight.
    Adler J
    Newsweek; 1998 May; 131(18):48. PubMed ID: 10178848
    [No Abstract]   [Full Text] [Related]  

  • 32. Shutters come off IPO window.
    Hodgson J
    Nat Biotechnol; 2002 Jan; 20(1):6. PubMed ID: 11753342
    [No Abstract]   [Full Text] [Related]  

  • 33. Does biotech M&A benefit investors?
    Jacobs T
    Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibiotics--an investment worth making?
    Christoffersen RE
    Nat Biotechnol; 2006 Dec; 24(12):1512-4. PubMed ID: 17160052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. R&D technology investments: misguided and expensive or a better way to discover medicines?
    Schmid EF; Smith DA
    Drug Discov Today; 2006 Sep; 11(17-18):775-84. PubMed ID: 16935744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. American Home bids $8.5 billion to buy New Jersey drug company.
    Scott L
    Mod Healthc; 1994 Aug; 24(32):12. PubMed ID: 10135368
    [No Abstract]   [Full Text] [Related]  

  • 37. Financing '98. Industry trends that investors are eyeing.
    Bell CS
    Contemp Longterm Care; 1998 Mar; 21(3):suppl 8-9. PubMed ID: 10177827
    [No Abstract]   [Full Text] [Related]  

  • 38. Merck's man in the hot seat.
    Simons J
    Fortune; 2004 Feb; 149(4):111-2, 114. PubMed ID: 14983668
    [No Abstract]   [Full Text] [Related]  

  • 39. Extensive consolidations continue in drug industry.
    Scott L
    Mod Healthc; 1994 Sep; 24(36):12. PubMed ID: 10136392
    [No Abstract]   [Full Text] [Related]  

  • 40. Italy must invest more in science and technology.
    Bertini I; Garattini S; Rappuoli R
    Nature; 2008 Apr; 452(7188):685. PubMed ID: 18401382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.